CHIVA Vein Center of New York Officially Approved, Marking a New Chapter as America’s First CHIVA Center

Dr. Smile Medical Group has reached a significant milestone with the official approval of the CHIVA Vein Center of New York by the New York State government. Set to open soon in Manhattan, this facility will become the first dedicated CHIVA treatment center in the United States. Collaborating closely with a team of American doctors, Dr. Smile Medical Group will introduce cutting-edge hemodynamic-based treatments and comprehensive healthcare services, significantly enhancing patient care and experiences in the region.

In parallel, Global CHIVA Management (GCM)—the U.S.-based Medical Service Organization (MSO) affiliated with Dr. Smile Medical Group—is gearing up to begin operations. GCM will provide robust management and support services for the New York CHIVA center, laying a solid foundation for further expansion across the U.S.

Later this year, Dr. Smile Medical Group will accelerate its strategic growth in China by reinforcing its existing medical institutions in Shanghai, Beijing, Shenzhen, Chengdu, and Jinan as regional hubs. This expansion aims to establish a comprehensive CHIVA network that integrates seamlessly with the global GCM network, promoting standardization and international collaboration in vein care.

Aligned with its global mission, Dr. Smile Medical Group is dedicated not only to promoting CHIVA treatment methodologies internationally but also pioneering innovative healthcare service models. Under the GCM global management framework, the proprietary VaricoSeek platform stands as a prime example of innovation. VaricoSeek transcends time zones, offering rapid, professional responses to inquiries from around the world, thus empowering clinicians and significantly improving patient outcomes for individuals dealing with varicose veins.

The establishment of CHIVA Vein Center of New York symbolizes a pivotal advancement in the international expansion of Dr. Smile Medical Group, paving the way for wider adoption of scientifically advanced treatments. This development promises to invigorate the global healthcare landscape, providing patients worldwide with greater access to innovative and effective medical solutions.